J.P. Morgan Day 3: Skyrizi Momentum Builds, What's Next For Amarin, Viatris Debuts And More

 
• By Jessica Merrill, Mandy Jackson, and Andrew McConaghie

Daily round-up from the J.P. Morgan Healthcare Conference in San Francisco: AbbVie's Skyrizi takes psoriasis lead, Amarin goes it alone, Viatris debuts, BeiGene on US drug pricing and Roche think neuroscience is the new oncology.

Classic view of historic traditional Cable Cars riding on famous California Street in morning light at sunrise with retro vintage style cross processing filter effect, San Francisco, California, USA
A roundup from the third day of the J.P. Morgan Healthcare Conference • Source: Shutterstock

More from Archive

More from Pink Sheet